UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine

Clinical pharmacokinetics, 2014-09, Vol.53 (9), p.837-847

2014

Volltextzugriff (PDF)

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device

Vaccine, 2005-09, Vol.23 (40), p.4867-4878

2005

Volltextzugriff (PDF)

Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study

Thrombosis and haemostasis, 2002-05, Vol.87 (5), p.817

2002

Volltextzugriff (PDF)

The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers

Clinical therapeutics, 2002-04, Vol.24 (4), p.583-594

2002

Volltextzugriff (PDF)

Valdecoxib does not impair platelet function

The American journal of emergency medicine, 2002-07, Vol.20 (4), p.275-281

2002

Volltextzugriff (PDF)

Population PK–PD model for Fc-osteoprotegerin in healthy postmenopausal women

Journal of pharmacokinetics and pharmacodynamics, 2008-08, Vol.35 (4), p.379-399

2008

Volltextzugriff (PDF)

Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589

Platelets (Edinburgh), 2007-08, Vol.18 (5), p.346-356

2007

Volltextzugriff (PDF)

Erratum to: Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine

Clinical pharmacokinetics, 2014-11, Vol.53 (11), p.1063-1063

2014

Volltextzugriff (PDF)

A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent

Investigative radiology, 1991-11, Vol.26 (11), p.980-986

1991

Volltextzugriff (PDF)

Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

Platelets (Edinburgh), 2007-01, Vol.18 (5), p.346-356

2007

Volltextzugriff (PDF)

Rapid and reversible modulation of platelet function in man by a novel P2Y 12 ADP-receptor antagonist, INS50589

Platelets (Edinburgh), 2007-01, Vol.18 (5), p.346-356

2007

Volltextzugriff (PDF)

Ferrioxamine as a Magnetic Resonance Contrast Agent Preclinical Studies and Phase I and II Human Clinical Trials

Investigative radiology, 1988-09, Vol.23 Suppl 1, p.S281-S285

1988

Volltextzugriff (PDF)

The development of specific IgG4 after immunotherapy with standardized extracts

New England and regional allergy proceedings, 1987-11, Vol.8 (6), p.429

1987

Volltextzugriff (PDF)

Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

Clinical drug investigation, 2001, Vol.21 (2), p.129-136

2001

Volltextzugriff (PDF)

Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet

Pharmaceutical research, 1987-10, Vol.4 (5), p.409-411

1987

Volltextzugriff (PDF)

Evaluation of the Pharmacokinetics and Safety of Ascending Single Oral Doses of GR43175 Administered to Healthy Male Volunteers

Cephalalgia, 1989-10, Vol.9 (10_suppl), p.414-415

1989

Volltextzugriff (PDF)

Ferrioxamine as a Magnetic Resonance Contrast Agent Preclinical Studies and Phase I and II Human Clinical Trials

Investigative radiology, 1988-09, Vol.23 (1), p.S286

1988

Volltextzugriff (PDF)

Recruiting for Post-Operative Pain Studies: Experiences over two Years

Clinical research and regulatory affairs, 1985, Vol.3 (4), p.451-451

1985

Volltextzugriff (PDF)

Diabetes and pregnancy: national trends over a 15 year period

Diabetologia, 2018-05, Vol.61 (5), p.1081-1088

2018

Volltextzugriff (PDF)

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland

Diabetologia, 2012-09, Vol.55 (9), p.2335-2342

2012

Volltextzugriff (PDF)

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure

Journal of medicinal chemistry, 2018-02, Vol.61 (3), p.1031-1044

2018

Volltextzugriff (PDF)

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

The FASEB journal, 2005-03, Vol.19 (3), p.422-424

2005

Volltextzugriff (PDF)

Do men develop type 2 diabetes at lower body mass indices than women?

Diabetologia, 2011-12, Vol.54 (12), p.3003-3006

2011

Volltextzugriff (PDF)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

Diabetologia, 2012-11, Vol.55 (11), p.2929-2937

2012

Volltextzugriff (PDF)

Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies

Cancer chemotherapy and pharmacology, 2016-04, Vol.77 (4), p.767-776

2016

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(61)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Diabetologia
(16)
Investigative Radiology
(4)
Chemmedchem
(3)
Platelets
(3)
Breast Cancer Research And Treatment
(2)
Cephalalgia
(2)
Clinical Pharmacokinetics
(2)
Environmental Pollution
(2)
Journal Of Medicinal Chemistry
(2)
Nature
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine

Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device

Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study

The pharmacokinetics of sumatriptan when administered with clarithromycin in healthy volunteers

Valdecoxib does not impair platelet function

Population PK–PD model for Fc-osteoprotegerin in healthy postmenopausal women

Rapid and reversible modulation of platelet function in man by a novel P2Y(12) ADP-receptor antagonist, INS50589

Erratum to: Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine

A Phase I Clinical Trial with Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Enhancement Agent

Rapid and reversible modulation of platelet function in man by a novel P2Y12 ADP-receptor antagonist, INS50589

Rapid and reversible modulation of platelet function in man by a novel P2Y 12 ADP-receptor antagonist, INS50589

Ferrioxamine as a Magnetic Resonance Contrast Agent Preclinical Studies and Phase I and II Human Clinical Trials

The development of specific IgG4 after immunotherapy with standardized extracts

Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

Bioavailability and pharmacokinetics of a new sustained-release potassium chloride tablet

Evaluation of the Pharmacokinetics and Safety of Ascending Single Oral Doses of GR43175 Administered to Healthy Male Volunteers

Ferrioxamine as a Magnetic Resonance Contrast Agent Preclinical Studies and Phase I and II Human Clinical Trials

Recruiting for Post-Operative Pain Studies: Experiences over two Years

Diabetes and pregnancy: national trends over a 15 year period

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland

Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

Do men develop type 2 diabetes at lower body mass indices than women?

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

Osimertinib Western and Asian clinical pharmacokinetics in patients and healthy volunteers: implications for formulation, dose, and dosing frequency in pivotal clinical studies

Aktive Filter

Suchergebnisse filtern